0000950170-24-127720.txt : 20241115 0000950170-24-127720.hdr.sgml : 20241115 20241115180918 ACCESSION NUMBER: 0000950170-24-127720 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20241115 FILED AS OF DATE: 20241115 DATE AS OF CHANGE: 20241115 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Certel Kaan CENTRAL INDEX KEY: 0002024211 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40657 FILM NUMBER: 241469344 MAIL ADDRESS: STREET 1: C/O OMEGA THERAPEUTICS, INC. STREET 2: 20 ACORN PARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Omega Therapeutics, Inc. CENTRAL INDEX KEY: 0001850838 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 140 FIRST STREET, SUITE 501 CITY: CAMBRIDGE STATE: MA ZIP: 02141 BUSINESS PHONE: (617) 949-4360 MAIL ADDRESS: STREET 1: 140 FIRST STREET, SUITE 501 CITY: CAMBRIDGE STATE: MA ZIP: 02141 4 1 ownership.xml 4 X0508 4 2024-11-15 0001850838 Omega Therapeutics, Inc. OMGA 0002024211 Certel Kaan C/O OMEGA THERAPEUTICS, INC. 140 FIRST STREET, SUITE 501 CAMBRIDGE MA 02141 true true false false See Remarks false Stock Option (Right to Buy) 0.8284 2024-11-15 4 A false 340000 0 A 2034-11-14 Common Stock 340000 340000 D The option vests and becomes exercisable with respect to 25% of the underlying shares on November 15, 2025 and in twelve (12) equal quarterly installments thereafter such that the option will become fully vested and exercisable on November 15, 2028, subject to the Reporting Person's continued service to the Issuer through each such vesting date. President and Chief Executive Officer /s/ Barbara Chan, Attorney-in-Fact for Kaan Certel 2024-11-15